IONS:NASDAQ
Ionis Pharmaceuticals Inc
$27.39
arrow_upward
+1.59%(+0.43) 1D
$27.47
arrow_upward
+0.29% (+0.080)bedtimeAfter hours
Closed: Nov 18, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IONS...
Open
$26.70
High
$28.04
Low
$26.70
Mkt. cap
4.56B
Avg. vol.
4.13M
Volume
32.00
52-wk high
$86.74
52-wk low
$26.55
EPS
-$3.33
Beta
0.43
Shares outstanding
166.54M
No. of employees
1K
Open
$26.70
High
$28.04
Low
$26.70
Mkt. cap
4.56B
Avg. vol.
4.13M
Volume
32.00
52-wk high
$86.74
52-wk low
$26.55
EPS
-$3.33
Beta
0.43
Shares outstanding
166.54M
No. of employees
1K
News stories
From web sources and news partners
Traders Union
·
6 hours ago
Why is Ionis Pharmaceuticals stock up 3% today?
Zacks
·
17 hours ago
Ionis' Tryngolza Gets EU Approval for Severe Hypertriglyceridemia
Benzinga
·
19 hours ago
Biogen Reports Two-Year Data Showing Diranersen Slows Early Alzheimer's Decline
Investing.com
·
21 hours ago
Guggenheim cuts Ionis stock price target to $65 on revenue miss
Profile
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
About Ionis Pharmaceuticals Inc
CEOBrett P. Monia Ph.D.
Employees1.48K
Founded1989
HeadquartersCarlsbad, California, United States
SectorHealth Care
IndustryBiotechnology
Websiteionis.com